Related Experiment Videos

Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk

Geoffrey Liu1, Paul Wheatley-Price, Wei Zhou

  • 1Applied Molecular Oncology/Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada. geoffrey.liu@uhn.on.ca

Insights

The MDM2 SNP309 gene variant does not directly increase lung cancer risk. However, it significantly interacts with smoking habits, altering cancer risk based on smoking intensity.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The tumor suppressor TP53 pathway is crucial for cancer development, regulating cell cycle and apoptosis.
  • Murine double minute-2 (MDM2) protein negatively regulates p53, a key tumor suppressor.
  • The MDM2 SNP309 polymorphism elevates MDM2 levels, potentially weakening the p53 pathway.

Purpose of the Study:

  • To investigate the association between the MDM2 SNP309 polymorphism and nonsmall cell lung cancer (NSCLC) risk in Caucasians.
  • To explore potential interactions between MDM2 genotypes and smoking history in relation to NSCLC risk.

Main Methods:

  • A case-control study involving 1,787 NSCLC patients and 1,360 healthy controls.
  • Genotyping for MDM2 SNP309 (rs2279744) was performed.
  • Statistical analyses adjusted for age, gender, histology, and smoking history, including pack-years.

Main Results:

  • No overall association was found between MDM2 genotypes and NSCLC risk.
  • A significant interaction (p=0.01) was observed between MDM2 genotypes and smoking.
  • Stratified analysis revealed that the G/G genotype increased lung cancer risk in never and light smokers but decreased it in moderate and heavy smokers compared to T/T.

Conclusions:

  • The MDM2 SNP309 polymorphism alone does not appear to influence NSCLC risk.
  • A significant gene-smoking interaction exists, where the risk associated with MDM2 SNP309 varies considerably with smoking pack-years.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...